Departments of Internal Medicine and Physiology, Wayne State University School of Medicine , Detroit, Michigan.
John D. Dingell Veterans Administration Medical Center , Detroit, Michigan.
Am J Physiol Regul Integr Comp Physiol. 2019 Feb 1;316(2):R172-R185. doi: 10.1152/ajpregu.00289.2018. Epub 2019 Jan 9.
The subfornical organ (SFO), a forebrain circumventricular organ that lies outside the blood-brain barrier, has been implicated in arterial pressure and baroreflex responses to angiotensin II (ANG II). We tested whether pharmacological inhibition or selective silencing of SFO ANG II type 1 receptors (ATR) of two-kidney, one-clip rats with elevated plasma ANG II decreases resting arterial pressure and renal sympathetic nerve activity (RSNA) and/or modulates arterial baroreflex responses of heart rate (HR) and RSNA. Male Sprague-Dawley rats underwent renal artery clipping [2-kidney, 1-clip (2K,1C)] or sham clipping (sham). After 6 wk, conscious rats instrumented with vascular catheters, renal nerve electrodes, and a cannula directed to the SFO were studied. In another set of experiments, rats were instrumented with hemodynamic and nerve radio transmitters and injected with scrambled RNA or silencing RNA targeted against ATR. Mean arterial pressure (MAP) was significantly higher in 2K,1C rats. Acute SFO injection with the ATR inhibitor losartan did not change MAP in sham or 2K,1C rats. Baroreflex curves of HR and RSNA were shifted rightward in 2K,1C rats. Losartan exerted no effect. SFO ATR knockdown did not influence MAP in sham rats but decreased MAP in 2K,1C rats, despite no change in plasma ANG II or resting RSNA. ATR knockdown prevented the reduction in maximum gain and slope of baroreflex responses of HR and RSNA; the reduced RSNA response to baroreceptor unloading was partially restored in 2K,1C rats. These findings show that ATR activation within the SFO contributes to hypertension and baroreflex dysfunction in 2K,1C rats and highlight the temporal requirement for reversal of these effects.
脑下器官(SFO)是一种位于血脑屏障外的前脑室周器官,它与血管紧张素 II(ANG II)的动脉压和压力反射反应有关。我们测试了通过给予二肾一夹型高血压大鼠(两肾一夹大鼠)药物抑制或 SFO 血管紧张素 II 型 1 受体(ATR)选择性沉默,是否可以降低静息动脉压和肾交感神经活性(RSNA),以及/或者调节心率(HR)和 RSNA 的动脉压力反射反应。雄性 Sprague-Dawley 大鼠进行了肾动脉夹闭[二肾一夹(2K,1C)]或假夹闭(假手术)。6 周后,对植入血管导管、肾神经电极和指向 SFO 的套管的清醒大鼠进行研究。在另一组实验中,大鼠被植入了血流动力学和神经无线电发射机,并注射了针对 ATR 的乱序 RNA 或沉默 RNA。2K,1C 大鼠的平均动脉压(MAP)明显升高。急性 SFO 注射 ATR 抑制剂 losartan 并未改变 sham 或 2K,1C 大鼠的 MAP。2K,1C 大鼠的 HR 和 RSNA 压力反射曲线向右偏移。losartan 没有作用。SFO ATR 敲低在 sham 大鼠中不影响 MAP,但降低了 2K,1C 大鼠的 MAP,尽管血浆 ANG II 或静息 RSNA 没有变化。ATR 敲低防止了 HR 和 RSNA 的压力反射反应的最大增益和斜率降低;2K,1C 大鼠中对压力感受器卸载的 RSNA 反应的部分恢复。这些发现表明,SFO 内的 ATR 激活导致 2K,1C 大鼠的高血压和压力反射功能障碍,并强调了逆转这些效应的时间要求。